Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.

Abstract:

:Binding of chemoattractant to polymorphonuclear leukocytes (PMNL) triggers a series of events like polymerization of actin and tubulin, orientation of cells, chemotaxis, increase in fluid pinocytosis and phagocytosis, and stimulation of microbicidal pathways which includes lysosomal degranulation and generation of reactive oxygen species. Earlier studies from our laboratory have shown that stimulation of chemotaxis, fluid pinocytosis, and actin polymerization of CML PMNL in response to a synthetic chemotactic peptide formyl-methionyl-leucyl-phenylalanine (fMLP) is significantly lower than that in normal PMNL. It is not known whether this lower response of CML PMNL to fMLP is a global phenomenon involving different chemoattractant receptors or is restricted to the fMLP pathway. We have evaluated chemoattractant induced degranulation process in normal and CML PMNL to fMLP, platelet activating factor (PAF), leukotriene B4 (LTB4), and an analogue of fMLP viz formyl-methionine-1 aminocyclooctane 1 carboxylic acid-phenylalanine-O-methionine (FACC8) using release of lysozyme as a parameter. We find that after stimulation with fMLP and FACC8, the mean percent release of lysozyme was significantly lower in CML PMNL as compared to that in normal cells (P < 0.001). There was no significant difference between the two after stimulation with PAF and LTB4. The results indicate that the fMLP pathway is suppressed in CML granulocytes whereas PAF and LTB4 pathways appear unaltered in these cells. We therefore also studied the kinetics of peptide-receptor interaction with a labelled hexapeptide fNLPNTL which binds to the fMLP receptor. Our results show that the number of fMLP receptors/cell is significantly lower in CML PMNL (P < 0.05) than in normal PMNL, while their affinity constants and dissociation constants were comparable.

journal_name

Am J Hematol

authors

Radhika V,Thennarasu S,Naik NR,Kumar A,Advani SH,Bhisey AN

doi

10.1002/(SICI)1096-8652(199607)52:3<155::AID-AJH4>

subject

Has Abstract

pub_date

1996-07-01 00:00:00

pages

155-64

issue

3

eissn

0361-8609

issn

1096-8652

pii

10.1002/(SICI)1096-8652(199607)52:3<155::AID-AJH4>

journal_volume

52

pub_type

杂志文章
  • Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.

    abstract::A 28-year-old asymptomatic male of Iranian Jewish (Meshadi) heritage was found on routine exam to have an erythrocytosis (RBC = 6.22 x 10(12)/l, Hgb = 19.2 g/dl, Hct = 58.9%). Splenomegaly was absent on physical exam. There was no family history of erythrocytosis. His oxygen dissociation curve was left-shifted with a ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20014

    authors: Hoyer JD,Allen SL,Beutler E,Kubik K,West C,Fairbanks VF

    更新日期:2004-04-01 00:00:00

  • Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.

    abstract::Cytotoxic agents like Hydroxyurea, Busulfan and Interferon-alpha are to date the most commonly used therapeutic approaches in Essential Thrombocythemia (ET). However, few data on the efficacy and safety of these agents in the long-term are currently available. We report a retrospective analysis of the long-term outcom...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21360

    authors: Palandri F,Catani L,Testoni N,Ottaviani E,Polverelli N,Fiacchini M,De Vivo A,Salmi F,Lucchesi A,Baccarani M,Vianelli N

    更新日期:2009-04-01 00:00:00

  • Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with isolated thrombocytopenia and hemorrhagic risk. While many children with ITP can be safely observed, treatments are often needed for various reasons, including to decrease bleeding, or to improve health related quality of life (HRQoL). There are a n...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.25479

    authors: Grace RF,Shimano KA,Bhat R,Neunert C,Bussel JB,Klaassen RJ,Lambert MP,Rothman JA,Breakey VR,Hege K,Bennett CM,Rose MJ,Haley KM,Buchanan GR,Geddis A,Lorenzana A,Jeng M,Pastore YD,Crary SE,Neier M,Neufeld EJ,Neu N

    更新日期:2019-07-01 00:00:00

  • Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

    abstract::The objective of this case-matched study was to compare the efficacy and toxicity of the addition of clarithromycin (Biaxin) to lenalidomide/low-dose dexamethasone (BiRd) vs. lenalidomide/low-dose dexamethasone (Rd) for newly diagnosed myeloma. Data from 72 patients treated at the New York Presbyterian Hospital-Cornel...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/ajh.21777

    authors: Gay F,Rajkumar SV,Coleman M,Kumar S,Mark T,Dispenzieri A,Pearse R,Gertz MA,Leonard J,Lacy MQ,Chen-Kiang S,Roy V,Jayabalan DS,Lust JA,Witzig TE,Fonseca R,Kyle RA,Greipp PR,Stewart AK,Niesvizky R

    更新日期:2010-09-01 00:00:00

  • Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia.

    abstract::Intravenous immunoglobulin (IVIG) therapy is associated with rare reports of thromboembolic events and severe hyponatremia. We hypothesized that IVIG therapy may result in hyperproteinemia, increased serum viscosity, and pseudohyponatremia. We conducted a prospective observational study to evaluate the incidence of hy...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10325

    authors: Steinberger BA,Ford SM,Coleman TA

    更新日期:2003-06-01 00:00:00

  • Five adults with mild sickle cell anemia share a beta S chromosome with the same haplotype.

    abstract::Five adult SS patients from Qatar, Turkey, and South Africa with mild disease, had greatly elevated Hb F and specific patterns of polymorphic sites on their beta S chromosomes. One subject had an alpha-thalassemia (-alpha/-alpha). The haplotypes were the common type #19, associated with severe disease, and type #31, n...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830200313

    authors: Bakioglu I,Hattori Y,Kutlar A,Mathew C,Huisman TH

    更新日期:1985-11-01 00:00:00

  • Inpatient management of sickle cell pain: a 'snapshot' of current practice.

    abstract::The Sickle Cell Disease Clinical Research Network (SCDCRN) designed the PROACTIVE Feasibility Study (ClinicalTrials.gov NCT00951808) to determine whether elevated serum levels of secretory phospholipase A2 (sPLA2) during hospitalization for pain would permit preemptive therapy of sickle cell acute chest syndrome (ACS)...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.22265

    authors: Miller ST,Kim HY,Weiner D,Wager CG,Gallagher D,Styles L,Dampier CD,Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).

    更新日期:2012-03-01 00:00:00

  • Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.

    abstract::To compare the features of sickle-cell anemia in Brazil with those in other locales, we studied the effects of the beta-globin-like gene cluster haplotype and alpha-thalassemia upon the clinical and hematological features in 85 patients. The distribution of haplotypes differed from that in the United States and Jamaic...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199610)53:2<72::AID-AJH3>3

    authors: Figueiredo MS,Kerbauy J,Gonçalves MS,Arruda VR,Saad ST,Sonati MF,Stoming T,Costa FF

    更新日期:1996-10-01 00:00:00

  • Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.

    abstract::In thalassemia, fetal hemoglobin (HbF) augmentation with hydroxycarbamide (also known as hydroxyurea) is not always successful. The expected parallel effects on red cell (RBC) membrane deformability, cell hydration, and membrane phospholipid organization, all important for extending RBC life span and increasing Hb, ha...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21266

    authors: Singer ST,Vichinsky EP,Larkin S,Olivieri N,Sweeters N,Kuypers FA,E\/beta Thalassemia Study Group.

    更新日期:2008-11-01 00:00:00

  • Geographic variability of hemophilia-associated AIDS in the United States: effect of population characteristics. Hemophilia-Associated AIDS Study Group.

    abstract::National AIDS surveillance suggests that approximately 3.5% of all hemophilic patients in the United States have developed AIDS as of February 1988; however, the cumulative incidence of AIDS among seropositive patients at individual hemophilia treatment centers (HTCs) has been reported to be as high as 12%. The purpos...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830320304

    authors: Stehr-Green JK,Jason JM,Evatt BL

    更新日期:1989-11-01 00:00:00

  • Potentiation of vincristine cytotoxicity by hormones: corticosteroids, androgens, estrogens and progestins.

    abstract::Using an in vitro system to evaluate the simultaneous use of two drugs, we previously have confirmed the synergism of vincristine and prednisolone cytotoxicity against lymphoid cells. Experiments were now carried out to determine whether other steroid hormones can be substituted for prednisolone. Partial or complete p...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830050405

    authors: Rosner F,Hirshaut Y,Grünwald HW,Deutsch S

    更新日期:1978-01-01 00:00:00

  • Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease.

    abstract::Sickle cell disease (SCD) is associated with early mortality. We sought to determine the incidence, cause, and risk factors for death in an adult population of patients with SCD. All patients aged >/=18 years seen at the Adult Sickle Cell Center at Duke University Medical Center between January 2000 and April 2005 wer...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21569

    authors: Fitzhugh CD,Lauder N,Jonassaint JC,Telen MJ,Zhao X,Wright EC,Gilliam FR,De Castro LM

    更新日期:2010-01-01 00:00:00

  • Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors.

    abstract::Hydroxyurea (HU) is a widely used cytotoxic agent that is known to induce fetal hemoglobin (HbF) production and is presently used to ameliorate the severity of pain episodes in patients with sickle cell anemia (HbSS). Previously we have shown that HU inhibits growth of burst forming unit-erythroid (BFU-E) colonies in ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/1096-8652(200011)65:3<227::aid-ajh9>3.0.co

    authors: Baliga BS,Pace BS,Chen HH,Shah AK,Yang YM

    更新日期:2000-11-01 00:00:00

  • Heparin-induced thrombocytopenia and thrombosis.

    abstract::Heparin, employed clinically for more than 50 years, is still a widely used anticoagulant. Unfortunately, some patients given this agent develop thrombocytopenia and thrombosis. Because this side effect can have catastrophic consequences, it is imperative that all clinicians caring for patients who receive heparin hav...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.20490

    authors: Davoren A,Aster RH

    更新日期:2006-01-01 00:00:00

  • In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.

    abstract::Hydroxyurea is a drug that is used to treat some patients with sickle cell disease. We have measured the deformability of sickle erythrocytes incubated in hydroxyurea in vitro and found that hydroxyurea acts to decrease the deformability of these cells. The deformability of normal erythrocytes was not significantly af...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.1098

    authors: Huang Z,Louderback JG,King SB,Ballas SK,Kim-Shapiro DB

    更新日期:2001-07-01 00:00:00

  • UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.

    abstract::Genetic modifiers contribute to phenotypic variability in patients with sickle cell anemia (SCA). The influence of the bilirubin UDP-glucuronosyltransferase (UGT) 1A1 (TA)(n)TAA promoter polymorphism on bilirubin levels and gallbladder disease in SCA was examined using prospectively collected data from the Cooperative...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21264

    authors: Carpenter SL,Lieff S,Howard TA,Eggleston B,Ware RE

    更新日期:2008-10-01 00:00:00

  • Primary prevention of sickle cell disease using preimplantation genetic testing and in vitro fertilization is cost-effective.

    abstract::Withdrawal: Primary prevention of sickle cell disease using preimplantation genetic testing and in vitro fertilization is cost-effective. The above article, published online on 20 August 2020 in Wiley Online Library (wileyonlinelibrary.com) as an Accepted Article, has been withdrawn by agreement between the authors, t...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25974

    authors: Cordeiro Mitchell CN,Pradhan A,Singh B,Naik RP,Baker VL,Lanzkron SM,Christianson MS,Pecker LH

    更新日期:2020-08-20 00:00:00

  • Coexistence of congenital afibrinogenemia and protein C deficiency in a patient.

    abstract::A rare association of congenital afibrinogenemia and hereditary protein C deficiency is described in a 37-year-old female who suffered from ischemic necrosis in the left first toe. The diagnosis of afibrinogenemia was assessed by the absence of fibrinogen in clotting and immunological assays. The diagnosis of heredita...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830410111

    authors: Hanano M,Takahashi H,Itoh M,Shibata A

    更新日期:1992-09-01 00:00:00

  • Management of acute chest wall sickle cell pain with nebulized morphine.

    abstract::This paper describes, for the first time, the utilization of nebulized morphine in the management of severe chest pain in two young adult African-American patients who suffered from generalized acute sickle cell painful episodes. While hospitalized, both patients developed new sharp chest wall pain, and were treated w...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20064

    authors: Ballas SK,Viscusi ER,Epstein KR

    更新日期:2004-06-01 00:00:00

  • A single-center experience in 20 patients with infantile malignant osteopetrosis.

    abstract::Infantile malignant osteopetrosis (IMO) includes various genetic disorders that affect osteoclast development and/or function. Genotype-phenotype correlation studies in IMO have been hampered by the rarity and heterogeneity of the disease and by the severity of the clinical course, which often leads to death early in ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21447

    authors: Mazzolari E,Forino C,Razza A,Porta F,Villa A,Notarangelo LD

    更新日期:2009-08-01 00:00:00

  • Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study.

    abstract::HIV infection has been associated with an increased risk of developing several types of malignancies, including aggressive peripheral T-cell lymphomas (PTCL). However, this is a rare occurrence with no more than a hundred cases reported in the literature. The purpose of this multicenter study is to describe the charac...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.21947

    authors: Castillo JJ,Beltran BE,Bibas M,Bower M,Collins JA,Cwynarski K,Diez-Martin JL,Hernandez-Ilizaliturri F,Horwitz SM,Montoto S,Pantanowitz L,Ribera JM,Vose JM

    更新日期:2011-03-01 00:00:00

  • Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.

    abstract::Autoimmune hemolytic anemia is thought to be mediated via auto-antibodies produced by lymphoid B cells. This may be an idiopathic process or secondary to an underlying infection or lymphoproliferative disorder. Conventional treatment comprises immunosuppression with corticosteroids and, in some cases, splenectomy. A p...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.20220

    authors: Ramanathan S,Koutts J,Hertzberg MS

    更新日期:2005-02-01 00:00:00

  • Autoimmune hemolytic anemia in patients infected with human immunodeficiency virus-1.

    abstract::Four men were diagnosed with human immunodeficiency virus infection (AIDS) and autoimmune hemolytic anemia (HIV-AIHA) during the years 1997-2000 at Cook County Hospital, Chicago. All patients presented with the acute onset of severe hemolytic anemia, fever, and splenomegaly. The direct and indirect antiglobulin tests ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10096

    authors: Koduri PR,Singa P,Nikolinakos P

    更新日期:2002-06-01 00:00:00

  • Nonspecific esterase of acute promyelocytic leukemia (M3).

    abstract::Leukemic cells of 43 patients with acute promyelocytic leukemia (M3) were investigated morphologically and cytochemically to determine the percentage of aberrant enzymes and whether or not the presence impacts on the clinical outcome. Twelve patients (27.9%) showed alpha-naphthyl acetate esterase (ANAE) activity in th...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830290306

    authors: Matsuo T,Jain NC,Bennett JM

    更新日期:1988-11-01 00:00:00

  • Transient ischemic attack in a patient with congenital protein-C deficiency during treatment with stanozolol.

    abstract::A patient with congenital protein-C deficiency was treated with stanozolol for 8 weeks to increase circulating levels of protein C. A rise in protein C was achieved, accompanied by an increase in factor II, factor X, antithrombin III, and protein S; but at the 8th week the patient suffered a transient ischemia attack....

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830290211

    authors: De Stefano V,Leone G,Teofili L,Ferrelli R,Pollari G,Antonini V,Bizzi B

    更新日期:1988-10-01 00:00:00

  • Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.

    abstract::We recently defined event-free survival at 24 months (EFS24) as a clinically relevant outcome for patients with DLBCL. Patients who fail EFS24 have very poor overall survival, while those who achieve EFS24 have a subsequent overall survival equivalent to that of the age- and sex-matched general population. Here, we de...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24223

    authors: Maurer MJ,Jais JP,Ghesquières H,Witzig TE,Hong F,Haioun C,Thompson CA,Thieblemont C,Micallef IN,Porrata LF,Ribrag V,Nowakowski GS,Casasnovas O,Bologna S,Morschhauser F,Morrison VA,Peterson BA,Macon WR,Copie-Bergman C

    更新日期:2016-02-01 00:00:00

  • Cryptococcal tonsillitis in a patient with chronic lymphocytic leukemia: an unusual manifestation of cryptococcal disease.

    abstract::We present a case of chronic tonsillitis in a patient with chronic lymphocytic leukemia. Despite empiric radiation and antibiotic therapy, the patient's sore throat and tonsillar enlargement persisted. Excisional biopsy of the involved tonsil revealed the presence of Cryptococcus neoformans. Blood cultures also yielde...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830250413

    authors: Korvick J,Yu VL

    更新日期:1987-08-01 00:00:00

  • Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.

    abstract::In patients with acute myeloid leukemia (AML), the presence of residual disease at day 14 after primary induction therapy warrants consideration of a second induction cycle. However, data to guide retreatment decisions in such patients are presently limited. Here, we retrospectively reviewed data from 176 patients wit...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24627

    authors: Griffin PT,Komrokji RS,Sweet K,Al Ali NH,Padron E,Kubal TE,List AF,Lancet JE

    更新日期:2017-03-01 00:00:00

  • Low dose cytosine arabinoside in acute myeloid leukemia: remission is not due to differentiation induction.

    abstract::A patient with acute nonlymphoblastic leukemia (FAB M4), showing a near tetraploid chromosome complement on his marrow cells, was treated with low dose cytosine arabinoside and achieved remission. During remission the near tetraploid marrow chromosome complement disappeared and reappeared upon relapse of leukemia. The...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830190412

    authors: Pinkerton PH,London B,Cowan DH

    更新日期:1985-08-01 00:00:00

  • Chronic lymphoproliferative disorder with regulatory T-cell phenotype.

    abstract::We report a case of T-cell chronic lymphoproliferative disorder (CLPD) that shows neither features of T-cell prolymphocytic leukemia nor disease progression for more than 34 months. Flow cytometric analyses of the lymphocytes revealed high expression of CD4 and CD25. Up-regulation of Foxp3, a master regulatory gene fo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20688

    authors: Kikuchi T,Katayama Y,Kubonishi S,Watanabe T,Watanabe Y,Matsuoka K,Maeda Y,Namba N,Masunari T,Nasu R,Ikeda K,Tanimoto M

    更新日期:2006-09-01 00:00:00